# Oral Mucosal Effects In Adult Smokers Associated With Two Nicotine Lozenge Formulations

> **NCT03087786** · PHASE1 · COMPLETED · sponsor: **Niconovum USA** · enrollment: 100 (actual)

## Conditions studied

- Safety Issues

## Interventions

- **DRUG:** Nicotine Bitartrate Lozenge 4mg
- **DRUG:** Nicotine Polacrilex 4Mg Lozenge

## Key facts

- **NCT ID:** NCT03087786
- **Lead sponsor:** Niconovum USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-21
- **Primary completion:** 2017-08-13
- **Final completion:** 2017-08-13
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03087786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03087786, "Oral Mucosal Effects In Adult Smokers Associated With Two Nicotine Lozenge Formulations". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03087786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*